CN103877440A - Medicine for treating rhinitis - Google Patents
Medicine for treating rhinitis Download PDFInfo
- Publication number
- CN103877440A CN103877440A CN201410139355.9A CN201410139355A CN103877440A CN 103877440 A CN103877440 A CN 103877440A CN 201410139355 A CN201410139355 A CN 201410139355A CN 103877440 A CN103877440 A CN 103877440A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- rhizoma
- fructus
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for treating rhinitis. The medicine consists of the following materials in parts by weight: 50-120 parts of magnolia flower, 50-120 parts of radix angelicae, 50-120 parts of bighead atractylodes rhizome, 20-50 parts of asarum, 50-120 parts of agastache rugosus, 100-200 parts of astragalus membranaceus, 50-80 parts of periostracum cicada, 20-70 parts of mint, 50-70 parts of divaricate saposhnikovia root, 100-120 parts of platycodon grandiflorum, 100-120 parts of rhizoma acori graminei, 30-70 parts of cocklebur fruit, 100-120 parts of honeysuckle, 100-120 parts of coix seeds, 100-150 parts of poria cocos, 100-120 parts of fructus forsythiae, 100-150 parts of lily, 100-120 parts of ligusticum wallichii, 100-120 parts of radix trichosanthis, 100-150 parts of pericarpium citri reticulatae, 100-120 parts of bitter orange, 1.0-1.6 parts of cyproheptadine hydrochloride and 1.2-2.0 parts of chlorpheniramine maleate. The medicine for treating the rhinitis has the characteristics of low cost, low toxic and side effect and significant curative effect, and is easy to prepare.
Description
Technical field
The present invention relates to tcm field, specifically, relate to a kind of medicament for the treatment of rhinitis.
Background technology
Allergic rhinitis (allergic rhinitis, AR) is a kind of allergic disease, is called again " allergic rhinitis ", is the abnormality disease of nasal membrane, can cause multiple complications.Be cardinal symptom mainly with ictal rhinocnesmus, nasal obstruction, sneeze, flowing water sample nasal mucus.Clinical classical symptom performance has rhinocnesmus, sneeze, water sample nasal mucus, nasal obstruction.Rhinocnesmus and continuously sneeze, often paroxysmal outbreak, nasal obstruction and nasal mucus, rise with night heavier morning subsequently.Rhinocnesmus sees most patient, and outer, the soft palate of nose, face, external auditory meatus etc. are located to itch sometimes, and Seasonal Incidence person eye itching is comparatively obvious.A large amount of clear water sample nasal mucus, but acute reaction trend being when weakening or disappearing, can reduce or retrogradation turbid, secondary infection person becomes and glues pus sample secretions.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of rhinitis.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of rhinitis, a kind of medicament for the treatment of rhinitis, the material that it comprises following weight proportioning: Flos Magnoliae 50-120 part, Radix Angelicae Dahuricae 50-120 part, Rhizoma Atractylodis Macrocephalae 50-120 part, Herba Asari 20-50 part, Herba Pogostemonis 50-120 part, Radix Astragali 100-200 part, Periostracum Cicadae 50-80 part, Herba Menthae 20-70 part, Radix Saposhnikoviae 50-70 part, Radix Platycodonis 100-120 part, Rhizoma Acori Graminei 100-120 part, Fructus Xanthii 30-70 part, Flos Lonicerae 100-120 part, Semen Coicis 100-120 part, Poria 100-150 part, Fructus Forsythiae 100-120 part, Bulbus Lilii 100-150 part, Rhizoma Chuanxiong 100-120 part, Radix Trichosanthis 100-120 part, Pericarpium Citri Reticulatae 100-150 part, Fructus Aurantii 100-120 part, cyproheptadine hydrochloride 1.0-1.6 part and chlorphenamine maleate 1.2-2.0 part.
Preferably, the kit for the treatment of rhinitis of the present invention is containing the material of following weight proportioning: 1.5 parts of 80 parts of Flos Magnoliaes, 80 parts of the Radixs Angelicae Dahuricae, 80 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Herba Asaris, 80 parts of Herba Pogostemoniss, 150 parts of the Radixs Astragali, 60 parts of Periostracum Cicadaes, 50 parts of Herba Menthaes, 60 parts of Radix Saposhnikoviaes, 110 parts of Radix Platycodoniss, 110 parts of Rhizoma Acori Graminei, 50 parts of Fructus Xanthii, 110 parts of Flos Loniceraes, 110 parts of Semen Coiciss, 120 parts, Poria, 110 parts of Fructus Forsythiaes, 120 parts of Bulbus Liliies, 110 parts of Rhizoma Chuanxiongs, 110 parts of Radix Trichosanthis, 120 parts of Pericarpium Citri Reticulataes, 110 parts of Fructus Aurantiis, 1.2 parts of cyproheptadine hydrochloride and chlorphenamine maleate.
More preferably, the medicament for the treatment of rhinitis of the present invention also comprises the material of following weight proportioning: 150 parts, ten liang of leaves, 150 parts of Herba Zornia Diphyllae, 150 parts of Herba Erigerontis Annuis, 900 parts, Bulbus Allii, 300 parts of Aspongopuss, 500 parts of Rhizoma Homalomenaes, 900 parts of Caulis Sargentodoxae, 600 parts of Semen Canavaliaes, 150 parts of Rhizoma Saururi (Herba Saururi)s, 600 parts of Flos Lonicerae, 900 parts of Folium Isatidiss, 500 parts of Rhizoma Bolbostematiss, 150 parts of Herba Senecionis Scandentiss, 150 parts of Folium Callicarpae Macrophyllaes, 600 parts of Rhizoma Kaempferiae, 600 parts of Fructus Ligustri Lucidi, 600 parts of Herba Gendarussaes, 300 parts, Rhizoma Gastrodiae, 700 parts of Radix Semiaquilegiaes, 800 parts of Coriolous Dersicolor (Fr.) Quel, 300 parts of Herba Equiseties Hiemalis, 500 parts of Cortex Acanthopanciss, 300 parts of Herba Orostachyos, 500 parts of Fructus Arctiis, 300 parts of Flos Rosae Chinensiss, 500 parts of Fructus Mumes, 150 parts of Fructus Polygoni Orientaliss, 900 parts of 600 parts of Rhizoma Polygonati Odorati and Herba Lysionoti Paucifloris.
Most preferably, described medicament can be tablet, dispersible tablet, powder or capsule.
Ten liang of leaves
Medical material Ji Yuan: be the Herb of Rhamnaceae Genus Chaydaia plant Herba Rednerved Chaydaiae.
Former plant: Herba Rednerved Chaydaiae Chaydaia rubrinervis (Levl.) C.Y.Wu ex Y. L.Chen[C.crenulata Hand.Mazz.]
Herba Zornia Diphyllae Latin formal name used at school Zornia gibbosa Spanoghe
The medicament for the treatment of rhinitis of the present invention has the advantages that cost is low, preparation is easy, toxic and side effects is little, curative effect is showing.
The specific embodiment
Embodiment 1:
Take 80 grams of Flos Magnoliaes, 80 grams of the Radixs Angelicae Dahuricae, 80 grams of the Rhizoma Atractylodis Macrocephalaes, 30 grams of Herba Asaris, 80 grams of Herba Pogostemoniss, 150 grams of the Radixs Astragali, 60 grams of Periostracum Cicadaes, 50 grams of Herba Menthaes, 60 grams of Radix Saposhnikoviaes, 110 grams of Radix Platycodoniss, 110 grams of Rhizoma Acori Graminei, 50 grams of Fructus Xanthii, 110 grams of Flos Loniceraes, 110 grams of Semen Coiciss, 120 grams, Poria, 110 grams of Fructus Forsythiaes, 120 grams of Bulbus Liliies, 110 grams of Rhizoma Chuanxiongs, 110 grams of Radix Trichosanthis, 120 grams of Pericarpium Citri Reticulataes, 110 grams of Fructus Aurantiis, 1.5 grams of 1.2 grams of cyproheptadine hydrochloride and chlorphenamine maleate, pulverize, cross 100 mesh sieves, mix homogeneously, then divide and install in 1000 capsule shells, obtain capsule of the present invention.
Embodiment 2:
Take 80 grams of Flos Magnoliaes, 80 grams of the Radixs Angelicae Dahuricae, 80 grams of the Rhizoma Atractylodis Macrocephalaes, 30 grams of Herba Asaris, 80 grams of Herba Pogostemoniss, 150 grams of the Radixs Astragali, 60 grams of Periostracum Cicadaes, 50 grams of Herba Menthaes, 60 grams of Radix Saposhnikoviaes, 110 grams of Radix Platycodoniss, 110 grams of Rhizoma Acori Graminei, 50 grams of Fructus Xanthii, 110 grams of Flos Loniceraes, 110 grams of Semen Coiciss, 120 grams, Poria, 110 grams of Fructus Forsythiaes, 120 grams of Bulbus Liliies, 110 grams of Rhizoma Chuanxiongs, 110 grams of Radix Trichosanthis, 120 grams of Pericarpium Citri Reticulataes, 110 grams of Fructus Aurantiis, 1.2 grams of cyproheptadine hydrochloride, 1.5 grams of chlorphenamine maleate, 150 grams, ten liang of leaves, 150 grams of Herba Zornia Diphyllae, 150 grams of Herba Erigerontis Annuis, 900 grams, Bulbus Allii, 300 grams of Aspongopuss, 500 grams of Rhizoma Homalomenaes, 900 grams of Caulis Sargentodoxae, 600 grams of Semen Canavaliaes, 150 grams of Rhizoma Saururi (Herba Saururi)s, 600 grams of Flos Lonicerae, 900 grams of Folium Isatidiss, 500 grams of Rhizoma Bolbostematiss, 150 grams of Herba Senecionis Scandentiss, 150 grams of Folium Callicarpae Macrophyllaes, 600 grams of Rhizoma Kaempferiae, 600 grams of Fructus Ligustri Lucidi, 600 grams of Herba Gendarussaes, 300 grams, Rhizoma Gastrodiae, 700 grams of Radix Semiaquilegiaes, 800 grams of Coriolous Dersicolor (Fr.) Quel, 300 grams of Herba Equiseties Hiemalis, 500 grams of Cortex Acanthopanciss, 300 grams of Herba Orostachyos, 500 grams of Fructus Arctiis, 300 grams of Flos Rosae Chinensiss, 500 grams of Fructus Mumes, 150 grams of Fructus Polygoni Orientaliss, 900 grams of 600 grams of Rhizoma Polygonati Odorati and Herba Lysionoti Paucifloris, pulverize, and crosses 100 mesh sieves, and mix homogeneously, then divides and install in 1000 capsule shells, obtains capsule of the present invention.
Experimental example
100 routine diagnosing patient standards references " diseases of eye, ear, nose and throat section Disease Diagnosis Standard " (Bei Zhengping, Shu Huai, all beams. diseases of eye, ear, nose and throat section Disease Diagnosis Standard [M]. Beijing: Science Press, 2001; Allergic rhinitis diagnostic criteria 295-296); Tcm diagnosis reference " tcm clinical practice disease Standardization of diagnosis and curative effect " (State Administration of Traditional Chinese Medicine. traditional Chinese medical science disease Standardization of diagnosis and curative effect [S] Nanjing: publishing house of Nanjing University, 1994; 124), clinical symptoms is with rhinocnesmus, nasal obstruction, stream clear water tears, to seasonal variations sensitivity.Bilateral inferior nasal meatus mucoid thing, middle concha nasalis inferior mucosal pallor edema are shown in clinical sign inspection, to vasoconstrictor sensitivity.The 100 routine patients that have classical symptom and make a definite diagnosis through training inspection are divided into two groups (each 50 examples), wherein first group of man's 25 example, female's 25 examples, age 18-60 year, average 36.5 years old; Course of disease March-1 year.Second group of man's 25 example, female's 25 examples, age 17-61 year, average 37.2 years old; Course of disease February-1 year.Two groups sex, age, the course of disease, etc. relatively there was no significant difference (P > 0.05) of aspect, there is comparability.
First group of capsule prepared by the oral embodiment 1 of patient, every day 1 time, each oral 1, treats 7 days continuously.
Second group of capsule prepared by the oral embodiment 2 of patient, every day 1 time, each oral 1, treats 7 days continuously.
Criterion of therapeutical effect
Reference " clinical disease diagnosis is according to curing improvement standard " and " tcm clinical practice disease Standardization of diagnosis and curative effect " (State Administration of Traditional Chinese Medicine. traditional Chinese medical science disease Standardization of diagnosis and curative effect [S] Nanjing: publishing house of Nanjing University, 1994; 124) evaluation curative effect.Clinical cure: symptom all disappears, not recurrence above in continuous 1 year; Effective: symptom all disappears, recurrence in 1 year, but symptom obviously alleviates; Effective: symptom is clearly better, recurrence again in half a year; Invalid: symptom is not improved or drug withdrawal recurs
Therapeutic outcome
In first group of patient, clinical cure 20 examples, effective 13 examples, effective 17 examples.In second group of patient, clinical cure 42 examples, effective 8 examples.In observation, do not occur serious adverse reaction, after treatment finishes, two groups of patients' blood, urine, stool routine and hepatic and renal function inspection are showed no extremely.
Claims (4)
1. treat the medicament of rhinitis for one kind, it is characterized in that the material that it comprises following weight proportioning: Flos Magnoliae 50-120 part, Radix Angelicae Dahuricae 50-120 part, Rhizoma Atractylodis Macrocephalae 50-120 part, Herba Asari 20-50 part, Herba Pogostemonis 50-120 part, Radix Astragali 100-200 part, Periostracum Cicadae 50-80 part, Herba Menthae 20-70 part, Radix Saposhnikoviae 50-70 part, Radix Platycodonis 100-120 part, Rhizoma Acori Graminei 100-120 part, Fructus Xanthii 30-70 part, Flos Lonicerae 100-120 part, Semen Coicis 100-120 part, Poria 100-150 part, Fructus Forsythiae 100-120 part, Bulbus Lilii 100-150 part, Rhizoma Chuanxiong 100-120 part, Radix Trichosanthis 100-120 part, Pericarpium Citri Reticulatae 100-150 part, Fructus Aurantii 100-120 part, cyproheptadine hydrochloride 1.0-1.6 part and chlorphenamine maleate 1.2-2.0 part.
2. the medicament for the treatment of rhinitis according to claim 1, is characterized in that the material that it comprises following weight proportioning: 1.5 parts of 80 parts of Flos Magnoliaes, 80 parts of the Radixs Angelicae Dahuricae, 80 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Herba Asaris, 80 parts of Herba Pogostemoniss, 150 parts of the Radixs Astragali, 60 parts of Periostracum Cicadaes, 50 parts of Herba Menthaes, 60 parts of Radix Saposhnikoviaes, 110 parts of Radix Platycodoniss, 110 parts of Rhizoma Acori Graminei, 50 parts of Fructus Xanthii, 110 parts of Flos Loniceraes, 110 parts of Semen Coiciss, 120 parts, Poria, 110 parts of Fructus Forsythiaes, 120 parts of Bulbus Liliies, 110 parts of Rhizoma Chuanxiongs, 110 parts of Radix Trichosanthis, 120 parts of Pericarpium Citri Reticulataes, 110 parts of Fructus Aurantiis, 1.2 parts of cyproheptadine hydrochloride and chlorphenamine maleate.
3. the medicament for the treatment of rhinitis according to claim 1 and 2, it is characterized in that also comprising the material of following weight proportioning: 150 parts, ten liang of leaves, 150 parts of Herba Zornia Diphyllae, 150 parts of Herba Erigerontis Annuis, 900 parts, Bulbus Allii, 300 parts of Aspongopuss, 500 parts of Rhizoma Homalomenaes, 900 parts of Caulis Sargentodoxae, 600 parts of Semen Canavaliaes, 150 parts of Rhizoma Saururi (Herba Saururi)s, 600 parts of Flos Lonicerae, 900 parts of Folium Isatidiss, 500 parts of Rhizoma Bolbostematiss, 150 parts of Herba Senecionis Scandentiss, 150 parts of Folium Callicarpae Macrophyllaes, 600 parts of Rhizoma Kaempferiae, 600 parts of Fructus Ligustri Lucidi, 600 parts of Herba Gendarussaes, 300 parts, Rhizoma Gastrodiae, 700 parts of Radix Semiaquilegiaes, 800 parts of Coriolous Dersicolor (Fr.) Quel, 300 parts of Herba Equiseties Hiemalis, 500 parts of Cortex Acanthopanciss, 300 parts of Herba Orostachyos, 500 parts of Fructus Arctiis, 300 parts of Flos Rosae Chinensiss, 500 parts of Fructus Mumes, 150 parts of Fructus Polygoni Orientaliss, 900 parts of 600 parts of Rhizoma Polygonati Odorati and Herba Lysionoti Paucifloris.
4. according to the medicament of the treatment rhinitis described in any one in claims 1 to 3, it is characterized in that, described medicament can be tablet, dispersible tablet, powder or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410139355.9A CN103877440A (en) | 2014-04-09 | 2014-04-09 | Medicine for treating rhinitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410139355.9A CN103877440A (en) | 2014-04-09 | 2014-04-09 | Medicine for treating rhinitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103877440A true CN103877440A (en) | 2014-06-25 |
Family
ID=50946776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410139355.9A Pending CN103877440A (en) | 2014-04-09 | 2014-04-09 | Medicine for treating rhinitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103877440A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104116914A (en) * | 2014-08-04 | 2014-10-29 | 喇全梅 | Composition for treating anaphylactic rhinitis and drug pillow made of same |
| CN104491483A (en) * | 2014-11-28 | 2015-04-08 | 湖南炎帝生物工程有限公司 | Traditional Chinese medicine composition for improving allergic diseases, preparation method and application thereof |
| CN104857414A (en) * | 2015-05-06 | 2015-08-26 | 燕爱凤 | Medicine composite for treating chronic simple rhinitis |
| CN105363012A (en) * | 2015-12-19 | 2016-03-02 | 许爱美 | Traditional Chinese medicine for treating rhinitis sicca |
| CN105726824A (en) * | 2016-03-25 | 2016-07-06 | 杨金龙 | Medicament for treating rhinitis |
| CN108236681A (en) * | 2016-12-24 | 2018-07-03 | 樊万军 | A kind of medicament for treating rhinitis |
| CN108283656A (en) * | 2018-03-05 | 2018-07-17 | 李智 | A kind of Chinese medicine preparation |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101297862A (en) * | 2008-06-02 | 2008-11-05 | 赵军海 | Capsule for treating rhinitis |
| US20080311196A1 (en) * | 2006-07-13 | 2008-12-18 | White Donna F | All Day Rhinitic Condition Treatment Regimen |
| CN101537098A (en) * | 2008-03-21 | 2009-09-23 | 北京中泰天和科技有限公司 | Pharmaceutical composition with effects of awakening consciousness, clearing away heat and toxic material, eliminating dampness and discharging pus and preparation method thereof |
| CN101926901A (en) * | 2010-09-01 | 2010-12-29 | 吴业刚 | Chinese medicinal oral liquid for treating chronic rhinitis and sinusitis and preparation method thereof |
-
2014
- 2014-04-09 CN CN201410139355.9A patent/CN103877440A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080311196A1 (en) * | 2006-07-13 | 2008-12-18 | White Donna F | All Day Rhinitic Condition Treatment Regimen |
| CN101537098A (en) * | 2008-03-21 | 2009-09-23 | 北京中泰天和科技有限公司 | Pharmaceutical composition with effects of awakening consciousness, clearing away heat and toxic material, eliminating dampness and discharging pus and preparation method thereof |
| CN101297862A (en) * | 2008-06-02 | 2008-11-05 | 赵军海 | Capsule for treating rhinitis |
| CN101926901A (en) * | 2010-09-01 | 2010-12-29 | 吴业刚 | Chinese medicinal oral liquid for treating chronic rhinitis and sinusitis and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 修霞: "玉屏风散合赛庚啶治疗过敏性鼻炎36例报告", 《江西中医药》, no. 2, 30 December 1996 (1996-12-30), pages 125 * |
| 刘波: "中西医治疗变应性鼻炎38例临床分析", 《中国民族民间医药》, no. 04, 28 February 2009 (2009-02-28), pages 61 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104116914A (en) * | 2014-08-04 | 2014-10-29 | 喇全梅 | Composition for treating anaphylactic rhinitis and drug pillow made of same |
| CN104491483A (en) * | 2014-11-28 | 2015-04-08 | 湖南炎帝生物工程有限公司 | Traditional Chinese medicine composition for improving allergic diseases, preparation method and application thereof |
| CN104491483B (en) * | 2014-11-28 | 2018-05-01 | 湖南炎帝生物工程有限公司 | A kind of Chinese medicine composition, its preparation method and application for improving anaphylactia |
| CN104857414A (en) * | 2015-05-06 | 2015-08-26 | 燕爱凤 | Medicine composite for treating chronic simple rhinitis |
| CN105363012A (en) * | 2015-12-19 | 2016-03-02 | 许爱美 | Traditional Chinese medicine for treating rhinitis sicca |
| CN105726824A (en) * | 2016-03-25 | 2016-07-06 | 杨金龙 | Medicament for treating rhinitis |
| CN108236681A (en) * | 2016-12-24 | 2018-07-03 | 樊万军 | A kind of medicament for treating rhinitis |
| CN108283656A (en) * | 2018-03-05 | 2018-07-17 | 李智 | A kind of Chinese medicine preparation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xiong et al. | Chinese herbal medicine for coronavirus disease 2019: A systematic review and meta-analysis | |
| CN103877440A (en) | Medicine for treating rhinitis | |
| CN1315525C (en) | Chinese traditional medicine for treating breast disease and preparing technique | |
| CN103340976B (en) | Drug for treating neck, shoulder, waist and leg pain | |
| CN104173638A (en) | Traditional Chinese medicine composition for treating rhinitis | |
| CN102488879B (en) | Medicinal composition for treating rheumatism | |
| CN104173704A (en) | Traditional Chinese medicine decoction for treating subacute thyroiditis | |
| CN102614306A (en) | Traditional Chinese herbal preparation for treating chronic nasosinusitis | |
| CN102688387B (en) | Medicine for treating subacute thyroiditis | |
| CN103705689A (en) | Drug composition for treating gout and gouty arthritis | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN103784793A (en) | Traditional Chinese medicine for treating climacteric syndrome | |
| CN104173834A (en) | Traditional Chinese medicine for treating meniere disease | |
| CN103860882A (en) | Medicinal preparation for treating chronic cervicitis | |
| CN103272115B (en) | Preparation for treating purpura | |
| CN103405635A (en) | Traditional Chinese medicine composition for treating middle and old aged constipation | |
| CN103071079B (en) | Traditional Chinese medicinal composition for treating prurigo nodularis | |
| CN105055781A (en) | Traditional Chinese medicine composition for treating female infertility | |
| CN110237119A (en) | A kind of pharmaceutical composition that treating mucous membrane of mouth class disease and preparation method and purposes | |
| CN104491832A (en) | Traditional Chinese medicine composition used for treating osteoproliferation | |
| CN102641361B (en) | Chinese herb preparation for treating abnormal menstruation | |
| CN104547562A (en) | Medicine for treating pulmonary tuberculosis and preparation method thereof | |
| CN103566219A (en) | Traditional Chinese medicine composition for treating cold | |
| CN104162043A (en) | Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis | |
| CN103721020A (en) | Blood circulation promoting and meridian unlocking granule for treating cerebral thrombosis and preparation method of granule |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140625 |
|
| RJ01 | Rejection of invention patent application after publication |